Investor Type | Firm |
Type of Fund | Family office |
Industries | BioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Pharmaceutical (& Medicine) |
Stages | Seed, Series A |
Investing | United States |
Investment Range | $100,000 - $5,000,000 |
Investment Sweet Spot | $1,500,000 |
Cure Ventures is a family office based investment fund located in Newport Beach, California, United States, with a sharp focus on the life sciences sector. They concentrate their investments within specific industries such as biotechnology, health technology and fitness, medical devices and hospital services, healthcare and wellness, and pharmaceuticals and medicine. Cure Ventures aims to identify and collaborate with pioneering companies operating from the nano to low-cap fields within these sectors. Their investment philosophy drives them to partner with businesses that showcase significant growth potential and are innovating the landscape of healthcare and medicine. They engage primarily at the seed and Series A funding stages, offering comprehensive financial support as well as strategic partnership. Cure Ventures has a broad investment range, with a minimum investment of $100,000, a maximum of $5,000,000, and a 'sweet spot' investment size of about $1,500,000, where they often find optimal alignment with their investment thesis. By injecting capital into promising ventures at these critical early stages, they seek to fuel advancements that can transform patient outcomes and revolutionize the healthcare industry. Their expertise and strategic placement in Newport Beach allows them to leverage a unique perspective on the burgeoning biotech scene in California, known as a hotbed for innovation and progress in the life sciences.